Antitumor activity of type III interferon alone or in combination with type I interferon against human non-small cell lung cancer (Q39480969)

12 September 2017

title

Antitumor activity of type III interferon alone or in combination with type I interferon against human non-small cell lung cancer (English)

1 reference

12 September 2017

1 reference

Takashi Suzuki

1 reference

12 September 2017

Katsutoshi Nakayama

1 reference

12 September 2017

Hitomi Fujie

1 reference

12 September 2017

Toshiaki Tanaka

1 reference

12 September 2017

Masatoshi Tagawa

1 reference

12 September 2017

Niu Kaijun

1 reference

12 September 2017

Mika Watanabe

1 reference

12 September 2017

Muneo Numasaki

1 reference

12 September 2017

publication date

10 October 2011

1 reference

12 September 2017

1 reference

12 September 2017

volume

102

1 reference

12 September 2017

1 reference

12 September 2017

page(s)

1977-1990

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02079.X

12 September 2017

1 reference

IL-28, IL-29 and their class II cytokine receptor IL-28R

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02079.X

IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02079.X

Biological activity of interleukins-28 and -29: comparison with type I interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02079.X

IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02079.X

Novel interferon-lambdas induce antiproliferative effects in neuroendocrine tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02079.X

Interferon-lambda induces G1 phase arrest or apoptosis in oesophageal carcinoma cells and produces anti-tumour effects in combination with anti-cancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02079.X

Interleukin-29 binds to melanoma cells inducing Jak-STAT signal transduction and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02079.X

IFNalpha and IFNlambda differ in their antiproliferative effects and duration of JAK/STAT signaling activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02079.X

Interferon-lambda as a potential therapeutic agent in cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02079.X

Characterization of the mouse IFN-lambda ligand-receptor system: IFN-lambdas exhibit antitumor activity against B16 melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02079.X

Antitumor activity of IFN-lambda in murine tumor models

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02079.X

Antitumor activity of type I and type III interferons in BNL hepatoma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02079.X

IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02079.X

IC101 induces apoptosis by Akt dephosphorylation via an inhibition of heat shock protein 90-ATP binding activity accompanied by preventing the interaction with Akt in L1210 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02079.X

Cisplatin (CDDP) specifically induces apoptosis via sequential activation of caspase-8, -3 and -6 in osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02079.X

Human parvovirus B19 induces cell cycle arrest at G(2) phase with accumulation of mitotic cyclins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02079.X

Constitutive expression of a 2',5'-oligoadenylate synthetase cDNA results in increased antiviral activity and growth suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02079.X

Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02079.X

PKR—A protein kinase regulated by double-stranded RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02079.X

Dependence of cyclin E-CDK2 kinase activity on cell anchorage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02079.X

Involvement of down-regulation of Cdk2 activity in hepatocyte growth factor-induced cell cycle arrest at G1 in the human hepatocellular carcinoma cell line HepG2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02079.X

Growth inhibition of human glioma cells by transfection-induced P21 and its effects on telomerase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02079.X

Senescence-like changes induced by expression of p21(waf1/Cip1) in NIH3T3 cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02079.X

Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02079.X

Hepatocyte growth factor induces redistribution of p21(CIP1) and p27(KIP1) through ERK-dependent p16(INK4a) up-regulation, leading to cell cycle arrest at G1 in HepG2 hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02079.X

Prognostic value of the immunohistochemical detection of p16INK4 expression in nonsmall cell lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02079.X

Induction of Cip/Kip and Ink4 cyclin dependent kinase inhibitors by interferon-alpha in hematopoietic cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02079.X

Differential expression of the p27Kip1 mRNA in IFN-sensitive and resistant cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02079.X

Prognostic implications of cell cycle, apoptosis, and angiogenesis biomarkers in non-small cell lung cancer: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02079.X

Cell cycle arrest and DNA endoreduplication following p21Waf1/Cip1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02079.X

10.1111/J.1349-7006.2011.02079.X

21 January 2018

Identifiers

DOI

1 reference

12 September 2017

1 reference